BBVA USA Bancshares’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
$2.24M Buy
3,926
+24
+0.6% +$13.7K 0.11% 184
2020
Q4
$2.28M Sell
3,902
-13
-0.3% -$7.58K 0.12% 166
2020
Q3
$1.99M Buy
3,915
+38
+1% +$19.4K 0.11% 164
2020
Q2
$1.75M Buy
3,877
+31
+0.8% +$14K 0.1% 172
2020
Q1
$1.35M Buy
3,846
+311
+9% +$109K 0.1% 185
2019
Q4
$1.31M Buy
+3,535
New +$1.31M 0.07% 219
2019
Q3
Sell
-3,630
Closed -$1.13M 387
2019
Q2
$1.13M Sell
3,630
-46
-1% -$14.4K 0.07% 235
2019
Q1
$1.12M Sell
3,676
-385
-9% -$118K 0.07% 225
2018
Q4
$943K Sell
4,061
-60
-1% -$13.9K 0.07% 233
2018
Q3
$1.29M Sell
4,121
-45
-1% -$14.1K 0.08% 228
2018
Q2
$1.2M Sell
4,166
-50
-1% -$14.4K 0.08% 228
2018
Q1
$1.06M Buy
4,216
+36
+0.9% +$9.01K 0.07% 251
2017
Q4
$998K Sell
4,180
-198
-5% -$47.3K 0.06% 267
2017
Q3
$972K Sell
4,378
-63
-1% -$14K 0.06% 269
2017
Q2
$1.01M Sell
4,441
-96
-2% -$21.7K 0.07% 258
2017
Q1
$905K Buy
4,537
+178
+4% +$35.5K 0.06% 281
2016
Q4
$795K Buy
4,359
+42
+1% +$7.66K 0.06% 291
2016
Q3
$707K Buy
4,317
+86
+2% +$14.1K 0.05% 297
2016
Q2
$605K Sell
4,231
-191
-4% -$27.3K 0.05% 315
2016
Q1
$604K Buy
4,422
+625
+16% +$85.4K 0.05% 327
2015
Q4
$526K Sell
3,797
-45
-1% -$6.23K 0.04% 333
2015
Q3
$516K Buy
3,842
+299
+8% +$40.2K 0.04% 314
2015
Q2
$534K Buy
3,543
+309
+10% +$46.6K 0.03% 338
2015
Q1
$437K Sell
3,234
-62
-2% -$8.38K 0.02% 420
2014
Q4
$397K Buy
3,296
+187
+6% +$22.5K 0.02% 435
2014
Q3
$352K Sell
3,109
-70
-2% -$7.93K 0.02% 446
2014
Q2
$381K Buy
3,179
+149
+5% +$17.9K 0.02% 435
2014
Q1
$388K Buy
3,030
+157
+5% +$20.1K 0.02% 418
2013
Q4
$355K Buy
2,873
+156
+6% +$19.3K 0.02% 428
2013
Q3
$319K Buy
2,717
+256
+10% +$30.1K 0.02% 420
2013
Q2
$276K Buy
+2,461
New +$276K 0.01% 406